Rami Burstein
Beth Israel Deaconess Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rami Burstein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:33 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04271202 · Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of ActionBeth Israel Deaconess Medical Center · completed · Chronic Migraine · principal investigator
- Ph2NCT01225263 · Statin/Vitamin D & Migraine StudyRami Burstein · completed · Migraine · study director
- Ph4NCT00719134 · The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine HeadacheBeth Israel Deaconess Medical Center · completed · Episodic Migraine · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Narrow Band Green Light Effects on Cortical Excitability and Responsivity in MigraineR01NS128045 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2023 to 2026 · $563,186 awarded in 2026Same name and institution; not confirmed by an ID
- Cortical Mechanisms of Headache: Beyond CSDR01NS094198 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2016 to 2020 · $378,438 awarded in 2020Same name and institution; not confirmed by an ID
- Photophobia during migraine: sensory, autonomic and emotional responses to lightR37NS079678 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2012 to 2018 · $475,750 awarded in 2018Same name and institution; not confirmed by an ID
- Migraine pathophysiology: neural basis of photophobiaR01NS069847 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2010 to 2014 · $369,282 awarded in 2014Same name and institution; not confirmed by an ID
- Migraine Pathophysiology:Thalamus and Extended AllodyniaR01NS051484 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2005 to 2009 · $372,754 awarded in 2009Same name and institution; not confirmed by an ID
- NEUROBIOLOGY OF ANOREXIA INDUCED BY MIGRAINE PAINR01DE013347 · NIDCR · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 2000 to 2004 · $258,825 awarded in 2004Same name and institution; not confirmed by an ID
- TRIGEMINOHYPOTHALAMIC TRACTR29DE010904 · NIDCR · BETH ISRAEL DEACONESS MEDICAL CENTER · fiscal years 1995 to 1999 · $117,833 awarded in 1999Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:33 UTC. The ranking covers the 200 most relevant of 30 PubMed records, and a shared surname and initials can bring in a namesake. All 30 on PubMed
- Altered placebo and drug labeling changes the outcome of episodic migraine attacks.Sci Transl Med · 2014287 citationsRCR 12.4
- 228 citationsRCR 10.6
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.Lancet Neurol · 2015219 citationsRCR 10.2
- Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.Headache · 2005153 citationsRCR 5.2
- Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.Headache · 2019120 citationsRCR 8.5
- 103 citationsRCR 3.4
- 86 citationsRCR 3.7
- Effects of caffeine ingestion on body fluid balance and thermoregulation during exercise.Can J Physiol Pharmacol · 199040 citationsRCR 2.3
- 35 citationsRCR 1.1
- 35 citationsRCR 5.5